These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29997009)

  • 1. A novel three base-pair deletion in domain two of the cardiac sodium channel causes Brugada syndrome.
    Tan BY; Wang L; Uttamchandani M; Barajas-Martinez H; Dumaine R; Morin N; Ching CK; Ho KL; Chong DTT; Chow W; Yap EPH; Moochhala S; Hu D; Yong RYY; Teo WS
    J Electrocardiol; 2018; 51(4):667-673. PubMed ID: 29997009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in Singapore.
    Tan BY; Yong RY; Barajas-Martinez H; Dumaine R; Chew YX; Wasan PS; Ching CK; Ho KL; Gan LS; Morin N; Chong AP; Yap SH; Neo JL; Yap EP; Moochhala S; Chong DT; Chow W; Seow SC; Hu D; Uttamchandani M; Teo WS
    Europace; 2016 Jun; 18(6):897-904. PubMed ID: 25829473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
    Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel
    Monasky MM; Micaglio E; Ciconte G; Rivolta I; Borrelli V; Ghiroldi A; D'Imperio S; Binda A; Melgari D; Benedetti S; Mitrovic P; Anastasia L; Mecarocci V; Ćalović Ž; Casari G; Pappone C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope.
    Makita N; Sumitomo N; Watanabe I; Tsutsui H
    Heart Rhythm; 2007 Apr; 4(4):516-9. PubMed ID: 17399644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation, R1632C, as a cause of atypical Brugada syndrome.
    Nakajima T; Kaneko Y; Saito A; Ota M; Iijima T; Kurabayashi M
    Heart Rhythm; 2015 Nov; 12(11):2296-304. PubMed ID: 26031372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual phenotypic transmission in Brugada syndrome.
    Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
    Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome.
    Nakajima T; Dharmawan T; Kawabata-Iwakawa R; Tamura S; Hasegawa H; Kobari T; Ota M; Tange S; Nishiyama M; Kaneko Y; Kurabayashi M
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12828. PubMed ID: 33463855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell transcriptomics trajectory and molecular convergence of clinically relevant mutations in Brugada syndrome.
    Tambi R; Abdel Hameid R; Bankapur A; Nassir N; Begum G; Alsheikh-Ali A; Uddin M; Berdiev BK
    Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H1935-H1948. PubMed ID: 33797273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations.
    Béziau DM; Barc J; O'Hara T; Le Gloan L; Amarouch MY; Solnon A; Pavin D; Lecointe S; Bouillet P; Gourraud JB; Guicheney P; Denjoy I; Redon R; Mabo P; le Marec H; Loussouarn G; Kyndt F; Schott JJ; Probst V; Baró I
    Basic Res Cardiol; 2014; 109(6):446. PubMed ID: 25341504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between sodium channel function and clinical phenotype in SCN5A variants associated with Brugada syndrome.
    Pearman CM; Denham NC; Mills RW; Ding WY; Modi SS; Hall MCS; Todd DM; Mahida S
    Hum Mutat; 2020 Dec; 41(12):2195-2204. PubMed ID: 33131149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic and molecular basis for sodium channel-mediated Brugada syndrome].
    Barajas-Martínez H; Hu D; Antzelevitch C
    Arch Cardiol Mex; 2013; 83(4):295-302. PubMed ID: 24269159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A balanced translocation disrupting SCN5A in a family with Brugada syndrome and sudden cardiac death.
    Yeates L; Ingles J; Gray B; Singarayar S; Sy RW; Semsarian C; Bagnall RD
    Heart Rhythm; 2019 Feb; 16(2):231-238. PubMed ID: 30170230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-Phenotype Correlation in a Family with Brugada Syndrome Harboring the Novel p.Gln371* Nonsense Variant in the
    Monasky MM; Micaglio E; Giachino D; Ciconte G; Giannelli L; Locati ET; Ramondini E; Cotugno R; Vicedomini G; Borrelli V; Ghiroldi A; Anastasia L; Pappone C
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
    Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
    Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico validation revealed the role of SCN5A mutations and their genotype-phenotype correlations in Brugada syndrome.
    Pham HM; Dang DP; Ta TD; Le TP; Phan DP; Trinh HA; Tran TV; Luong TLA; Nguyen HM; Bui TH; Tran TH; Ta TV; Tran VK
    Mol Genet Genomic Med; 2023 Dec; 11(12):e2263. PubMed ID: 37547970
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wijeyeratne YD; Tanck MW; Mizusawa Y; Batchvarov V; Barc J; Crotti L; Bos JM; Tester DJ; Muir A; Veltmann C; Ohno S; Page SP; Galvin J; Tadros R; Muggenthaler M; Raju H; Denjoy I; Schott JJ; Gourraud JB; Skoric-Milosavljevic D; Nannenberg EA; Redon R; Papadakis M; Kyndt F; Dagradi F; Castelletti S; Torchio M; Meitinger T; Lichtner P; Ishikawa T; Wilde AAM; Takahashi K; Sharma S; Roden DM; Borggrefe MM; McKeown PP; Shimizu W; Horie M; Makita N; Aiba T; Ackerman MJ; Schwartz PJ; Probst V; Bezzina CR; Behr ER
    Circ Genom Precis Med; 2020 Dec; 13(6):e002911. PubMed ID: 33164571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.